Close

Press Releases

Pfizer gets optimistic response from CHMP for its CHEMOTHERAPY and MYELOGENOUS LEUKEMIA

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted positive opinions recommending that two Pfizer hematology medicines be granted marketing authorizations in the European Union (EU). MYLOTARGโ„ข...

Elsevier collaborates with Beijing University of Chinese Medicine to enable deeper research into traditional Chinese medicine

As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in science and health, announced that it is working with Beijing University of Chinese Medicine (BUCM) to create a new taxonomy for traditional...

Enhanced ICP-MS Triple Quadrupole Technology for Ultra-trace Analysis

Semiconductor wafer fabrication plants and ultra-high purity chemical suppliers can now strengthen their monitoring of trace elements within challenging sample matrices with a new triple quadrupole inductively coupled plasma mass spectrometer (ICP-MS), offering sub-parts-per-trillion detectionโ€”making it an ideal solution...

Saneca Pharma renews Pharmascience agreement following successful quality audit

Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canadaโ€™s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form. The agreement, which follows...

CRF Health Scoops 2018 TrialConsentยฎ Hat Trick as CARE Award Finalist

CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its TrialConsentยฎ electronic informed consent solution has been shortlisted for the โ€˜Best Patient-Focused Technological Developmentโ€™ category in the 2018 Clinical & Research Excellence (CARE)...

Biotech uses New Technology to fight Cardiovascular Diseases

Despite significant technological advances in technology, cardiovascular diseases (CVDs) remain the number one cause of death globally. CVDs are a group of disorders of both the heart and blood vessels that can lead to heart attacks and strokes. ...

Alma Lasers Inc., receives new FDA clearance soprano ICE platform, Indicating a new era in Aesthetic technology Advancement

Alma Lasers, a subsidiary of Sisram Medical Ltd , the leading global innovator of laser light-based, radio frequency and ultrasound solutions for the aesthetic and surgical markets and the #1 rated leading provider of energy-based surgical and medical aesthetic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป